Therapeutic Vaccines Market
Therapeutic Vaccines Market - Global Industry Assessment & Forecast
#
Pages:
250
Base Year:
2023
Jan - 2024
Format:
Report Code:
VMR-2384
Segments Covered
By
Product Addiction Vaccines, Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines
-
By
Technology Autologous Vaccines, Allogeneic Vaccines
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 31 Billion |
 Revenue 2032:
|
USD 140 Billion |
 Revenue CAGR
(2024 - 2032): |
18.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Therapeutic Vaccines Market Segment Analysis
- Therapeutic Vaccines Product Outlook (Revenue, USD Million, 2018 - 2030)
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Therapeutic Vaccines Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Autologous Vaccines
- Allogeneic Vaccines
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
-
North America Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- U.S.
- U.S. Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- U.S. Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- U.S. Therapeutic Vaccines Market, by Product
- Canada
- Canada Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Canada Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Canada Therapeutic Vaccines Market, by Product
-
Mexico
- Mexico Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Mexico Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Mexico Therapeutic Vaccines Market, by Product
-
North America Therapeutic Vaccines Market, by Product
- Europe
-
Europe Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
-
Europe Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- U. K.
- U.K. Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- U.K. Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- U.K. Therapeutic Vaccines Market, by Product
- France
- France Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- France Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- France Therapeutic Vaccines Market, by Product
-
Germany
- Germany Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Germany Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Germany Therapeutic Vaccines Market, by Product
-
Italy
- Italy Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Italy Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Italy Therapeutic Vaccines Market, by Product
-
Spain
- Spain Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Spain Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Spain Therapeutic Vaccines Market, by Product
-
Rest of Europe
- Rest of Europe Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Rest of Europe Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Rest of Europe Therapeutic Vaccines Market, by Product
-
Europe Therapeutic Vaccines Market, by Product
- Asia Pacific
-
Asia Pacific Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
-
Asia Pacific Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- China
- China Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- China Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- China Therapeutic Vaccines Market, by Product
- Japan
- Japan Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Japan Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Japan Therapeutic Vaccines Market, by Product
-
Germany
- Germany Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Germany Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Germany Therapeutic Vaccines Market, by Product
-
India
- India Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- India Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- India Therapeutic Vaccines Market, by Product
-
South Korea
- South Korea Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- South Korea Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- South Korea Therapeutic Vaccines Market, by Product
-
South East Asia
- South East Asia Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- South East Asia Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- South East Asia Therapeutic Vaccines Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Rest of Asia Pacific Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Rest of Asia Pacific Therapeutic Vaccines Market, by Product
-
Asia Pacific Therapeutic Vaccines Market, by Product
- Latin America
-
Latin America Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
-
Latin America Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Brazil
- Brazil Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Brazil Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Brazil Therapeutic Vaccines Market, by Product
- Argentina
- Argentina Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Argentina Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Argentina Therapeutic Vaccines Market, by Product
-
Rest of Latin America
- Rest of Latin America Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Rest of Latin America Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Rest of Latin America Therapeutic Vaccines Market, by Product
-
Latin America Therapeutic Vaccines Market, by Product
- Middle East & Africa
-
Middle East & Africa Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
-
Middle East & Africa Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- GCC Countries
- GCC Countries Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- GCC Countries Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- GCC Countries Therapeutic Vaccines Market, by Product
- South Africa
- South Africa Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- South Africa Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- South Africa Therapeutic Vaccines Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Therapeutic Vaccines Market, by Product
- Addiction Vaccines
- Autoimmune Disease Vaccines
- Neurological Disease Vaccines
- Infectious Disease Vaccines
- Rest of Middle East & Africa Therapeutic Vaccines Market, by Technology
- Autologous Vaccines
- Allogeneic Vaccines
- Rest of Middle East & Africa Therapeutic Vaccines Market, by Product
-
Middle East & Africa Therapeutic Vaccines Market, by Product
- North America
Vantage Market
Research | 15-Feb-2024
FAQ
Frequently Asked Question
What is the global demand for Therapeutic Vaccines in terms of revenue?
-
The global Therapeutic Vaccines valued at USD 31 Billion in 2023 and is expected to reach USD 140 Billion in 2032 growing at a CAGR of 18.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Agenus Inc. (U.S.), Argos Therapeutics Inc. (U.S.), Bavarian Nordic A/S (Denmark), Cel-Sci Corp. (U.S.), CSL Ltd. (Australia), Emergent Biosolutions Inc. (U.S.), GSK PLC (UK), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Sanofi S.A. (France).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 18.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Therapeutic Vaccines include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Therapeutic Vaccines in 2023.
